Agilent | Trusted AnswersAgilent | Trusted Answers

Peak Performance

Data-Driven Solutions for Complex Biopharma Demands

Peak Performance | Agilent

Join us for a seminar designed to inspire innovation and collaboration.

Mark your calendar for November 6th and join Agilent at Back 9 Golf and Entertainment.  Explore the latest advancements in automated sample preparation, protein analysis, and data management through dynamic discussions and live demonstrations. This event will showcase cutting-edge techniques for the analysis and characterization of biomolecules, including monoclonal antibodies (mAbs), GLP-1 agonists, and synthetic oligonucleotides. Alongside the science, enjoy delicious food, valuable networking opportunities, and a few fun swings at the tee. Whether you're driving scientific breakthroughs, streamlining workflows, conducting lab analyses, or managing lab operations, this event offers a unique opportunity to learn and connect.

Learning Objectives

  1. Eliminate inefficiencies in biopharmaceutical workflows through automated sample preparation.

  2. Explore the ProteoAnalyzer System and its capabilities for high-throughput, parallel CE analysis.

  3. Gain insights into advanced LC and LC-MS techniques for comprehensive biomolecule analysis—from mAbs to oligonucleotides.

  4. Experience live demonstrations of Agilent SLIMS and cell analysis technologies that empower lab automation and therapeutic discovery.

Agenda

8:00 a.m. - 8:30 a.m - Registration & Breakfast

8:30 a.m. - 9:00 a.m - Welcome and Introductions

9:00 a.m. - 9:45 a.m. Automated Sample Preparation for Biopharmaceutical Analysis: Removing inefficiencies and variability - Presented by Kenda Evans Ph.D
Explore the latest developments in methods, column chemistries, and techniques for protein and peptide-based therapeutics, including enzymatic digestion workflows, reverse phase cleanup, and more

9:45 a.m. - 10:15 a.m. Discover the ProteoAnalyzer System: Automated Protein Analysis Parallel to None - Presented by Price Cole
The Agilent ProteoAnalyzer system is a parallel capillary electrophoresis instrument that automates the capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) analysis of reduced and non-reduced protein samples. Able to separate 12 samples in as little as 30 minutes, this system is designed to eliminate the laborious process of SDS-PAGE gel preparation, staining/destaining, and analysis so you can focus on results. The ProteoAnalyzer system separates proteins ranging from 10 to 240 kDa, enabling the analysis of proteins over a wide size range in a single run. The discrete individual capillaries are rejuvenated between every separation, allowing for the analysis of diverse samples, including monoclonal antibodies, biosimilars, protein purification fractions, and crude lysates.

10:15 a.m - 10:30 a.m - Break

10:30 a.m. - 11:15 a.m.
Achieving Superior Results in Biologic Characterization: From Analytical to Preparative LC - Presented by Lance Kasper
Unlock the full potential of your biologics workflow with Agilent’s InfinityLab III LC Series—now featuring both UHPLC and Prep LC solutions for comprehensive characterization of Monoclonal Antibodies, Bispecific Antibodies, and Antibody-Drug Conjugates. This session highlights how our technology enables seamless scale-up from analytical to preparative workflows, delivering consistent results with superior resolution, sensitivity, and reproducibility.

11:15 a.m - 12:00 p.m Comprehensive Characterization of Biomolecules Using LC-MS: From Monoclonal Antibodies to Synthetic Oligonucleotides - Presented by Christopher Colangelo Ph.D
In this presentation, we will explore advanced techniques for the LC-MS characterization of biomolecules, including monoclonal antibodies (mAbs), GLP-1 agonists, and synthetic oligonucleotides. We will focus on utilizing LC-MS mass spectrometry for the rapid and automated detection of these complex biomolecules. By extending to high-resolution mass spectrometry like the Agilent 6545XT AdvanceBio LC/Q-TOF system with microdroplet technology, we can provide comprehensive insights into the structure and function of these complex biomolecules.

12:00 p.m. - 12:30 p.m. Advances in Column and Preparation Technologies from Peptides to Proteins - Presented by Luzelva Shaw
Developing methods for protein and peptide CQAs requires both robustness and scalability.  We will discuss the latest developments and column chemistries for peptide and protein-based therapeutics, including new developments in SEC, reverse phase, and other relevant chemistries.

12:30 p.m. - 1:15 p.m. LUNCH

1:15 p.m - 2:00 p.m Empowering Scientific Discovery and Advancing Groundbreaking Therapeutics with Agilent Cell Analysis - Presented by Steve Kryanik Ph.D
An overview of Agilent’s Cell Analysis Solutions portfolio. Agilent’s commitment to empowering scientific discovery and advancing therapeutics has provided innovative technologies that are tailored for life sciences and human health research.  These solutions cover a wide array of research areas, including cancer biology, immunology, stem cell research, virology, toxicology, neuroscience, and drug discovery

2:00 p.m - 2:30 p.m Lab Automation - Live SLIMS Demonstration - Presented by Dylan Young
Support your automation journey with the SLIMS Lab Execution System. This live demonstration delves in to SLIMS’ efficient inventory management, accessioning, automated method assignment and scheduling, instrument automation, and workflow execution. We’ll cap this short demonstration with an exploration of how AI may be employed to save effort and time-to-value.

2:30 p.m - 4:30 p.m - Networking/Golf Play

Venue/Date/Time

Date: November 6th, 2025 

Time: 08:00 a.m - 04:30 p.m

Location:
Back 9 Golf & Entertainment
1415 Drover St
Indianapolis, IN 46221

*Back 9 is conveniently located downtown, just 1 mile south of Lucas Oil Stadium! They have an expansive parking lot around their building at 1415 Drover St. that is free of charge. Please park in the main lot in front of our building or in their smaller side lot!*

Featured Speakers

  1. Kenda Evans Ph.D - Kenda received her Ph.D. from The University of Texas Health Science Center in San Antonio in the field of Pharmacology with a focus on the signal transduction pathway for the Serotonin 1A (5-HT1A) receptor. Kenda’s post-doctoral work occurred at the University of Houston School of Pharmacy where she studied the effects of inverse agonists and antagonists on Beta receptors in both respiratory and cardiovascular models. Kenda then joined Encysive Pharmaceuticals where she was the lead for the high throughput screening team as well as project manager for target drugs. Following this, Kenda joined PerkinElmer as a high throughput screening Field Application Scientist. For more than fourteen years now, Kenda has been a part of the Automation Team at Agilent and is currently in the role of Automation Workflow Specialist where she is helping researchers find the right solution for their automation needs and working to enable more fully applicated workflows.

  2. Lance Kasper - Lance Kasper is an HPLC applications scientist at Agilent Technologies based in Wood Dale, Illinois. Since 2016, he has supported biopharma customers with biomolecule HPLC method development and transfer, advising on column and instrument selection and providing hands-on training. Prior to joining Agilent, he developed HPLC methods at a contract research organization and worked on lab automation for peptide synthesis and protein digestion. He holds an M.S. in Medical Biotechnology from the University of Illinois. Lance’s work centers on practical workflows that help development and QC teams generate reliable data.

  3. Christopher Colangelo Ph.D - Christopher Colangelo, PhD, MBA is the Agilent Biopharma Business Development Leader for the Americas. Prior to joining Agilent, he was the 5th employee and co-inventor of the 454-sequencing platform. In 2003, Chris joined Yale University as a Research Faculty in where he mentored and supervised a research group producing 60+ peer-reviewed publications and directed core research laboratories for four NIH P30 grants, totaling over $21 million worth of research funds. In 2017, Chris joined Agilent to lead the team helping customers develop, test, and implement end-to-end biopharmaceutical workflows.

  4. Luzelva Shaw - Luzelva Shaw have been with Agilent Technologies for three years where I have helped biopharma labs across the Pacific Northwest and Midwest find solutions to their large molecule analytical challenges. I hold a Biology degree from Concordia University, a Master of Science from Texas State University, and have15 years of experience working in pharma and biopharma industry. 

  5. Steve Kryanik Ph.D - Steve Kraynik, Ph.D., is the Agilent Cell Analysis account manager for Indiana, Kentucky, and southwestern Ohio, as well as the BioTek Product Specialist.  He has been working with the BioTek brand since 2015.  Before that, he did his undergraduate degree in biochemistry at The Ohio State University and a Ph.D. in Pharmacology at the University of Washington.

  6. Dylan Young - Dylan Young, a seaworthy, test-driven engineer and Business Development Manager with 20 years of experience, helps labs create in silico solutions for in silica instruments, solving common lab problems. At Agilent Technologies, he presents SLIMS, an end-to-end lab execution system. SLIMS provides fast, flexible, and calibrated solutions for all labs. It specializes in inventory management, workflow execution, and all types of seamless instrument integrations, from chronometers to spectrometers.

Register Here

Your Personal Data

* This field is required

Please select your application interest(s) from choices below.

Please select your technique(s) from choices below.

Your Purchase Plan











For full details of how we will treat your information please view our privacy policy: www.agilent.com/home/privacy-policy